Oncology
Mary-Ellen Taplin, MD
Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Mary-Ellen Taplin, MD, is a distinguished medical oncologist specializing in genitourinary cancers, with a primary focus on prostate cancer, bladder cancer, kidney cancer, and testis cancer. She serves as Institute Physician and Director of Clinical Research for the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute and Brigham and Women's Hospital. Her clinical practice emphasizes hormone therapy, chemotherapy, and participation in clinical trials, providing comprehensive ca
40+
Years in Practice
Credentials
Board Certifications
- Medical Oncology, 1993
- Hematology, 1996
- Internal Medicine, 1989
Education & Training
- University of Massachusetts Medical School — M.D., 1986
- Beth Israel Deaconess Medical Center — Fellowship, Hematology/Oncology, 1990-1993
- University of Massachusetts Medical Center — Chief Medical Resident, Internal Medicine
- University of Massachusetts Medical Center — Residency, Internal Medicine, 1987-1990
Peer Recognition
- Castle Connolly — Top Doctor
2007-2026 (20 years)
2019-2025 (7 years)
2015
Recognition & Leadership
Awards & Honors
- Dana-Farber Cancer Center Medical Oncology Teaching Award 2009
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
- Newton-Wellesley Hospital
Languages
English
Experience
40+ years in practice